Melanotan I

Dermatology practical & conceptual · 2025

Researchers reviewed recent advancements in the treatment of vitiligo, a skin condition that causes loss of pigmentation and affects many people's quality of life. They found that new therapies, including Janus kinase inhibitors and targeted light treatments, show promise in managing this condition.

• Researchers observed that vitiligo is linked to the destruction of melanocytes, influenced by factors like inflammation and genetics.
• The review highlighted new treatment options such as Janus kinase inhibitors and prostaglandin analogues that could improve outcomes for patients.
• Recent developments in understanding vitiligo's mechanisms have led to more effective therapeutic strategies.

Postepy dermatologii i alergologii · 2024

Researchers reviewed the use of afamelanotide, a synthetic hormone, in treating skin conditions, particularly erythropoietic porphyria (EPP), which causes painful sensitivity to light. They found that afamelanotide improved patients' tolerance to artificial light and allowed them to spend more time in sunlight without pain.

• Researchers observed that afamelanotide enhances eumelanin production by activating the melanocortin-1 receptor.
• The study highlighted afamelanotide's effectiveness in increasing pain-free time in sunlight for patients with EPP.
• The review encourages considering afamelanotide as a treatment option in dermatology, especially for EPP.

Journal of pineal research · 2024

Researchers reviewed the structure and signaling of melatonin receptors, which are important for how melatonin interacts with cells in the body. They noted that different species have various receptor subtypes, particularly in mammals, which play a role in melatonin's effects.

• Researchers found that melatonin binds specifically to its receptors, influencing various biological processes.
• The study observed different subtypes of melatonin receptors across species, highlighting their diversity.
• Researchers noted the significance of these receptors in understanding melatonin's role in health and biology.

International journal of molecular sciences · 2023

Researchers reviewed the complex disease vitiligo, which affects patients' quality of life and currently lacks a fully effective treatment. They analyzed various existing and emerging therapies, noting that while many options are available, none stand out as completely satisfactory, highlighting the need for ongoing drug development.

• Researchers observed that vitiligo has a multifactorial nature impacting patients significantly.
• The study reviewed 116 articles on treatments, including phototherapy and various medications, assessing their mechanisms, efficacy, and safety.
• Despite multiple therapeutic options, there is no clearly superior treatment for vitiligo, emphasizing the necessity for further research and development.

International journal of molecular sciences · 2023

Researchers reviewed the causes and treatment options for vitiligo, a skin condition affecting 0.5% to 2% of people worldwide. They found that genetic factors and immune responses may play a role in its development and highlighted new treatment methods, including topical and oral medications currently being studied.

• Researchers observed that the exact causes of vitiligo remain unclear, with several theories suggesting genetic predisposition and immune system involvement.
• The study highlighted new treatment options, including topical ruxolitinib, which has been approved, and other agents like oral ritlecitinib and afamelanotide that are in clinical trials.
• Advancements in molecular and genetic research may lead to the development of more effective therapies for vitiligo.

International journal of molecular sciences · 2023

Researchers observed that vitiligo, a skin condition characterized by white patches due to the loss of pigment cells, affects about 1-2% of the population. The study highlights various factors contributing to this loss, including inflammation and autoimmunity, and discusses recent advancements in targeted treatments that show promise with fewer side effects.

• Researchers found that vitiligo results from a complex interplay of factors leading to the loss of melanocytes, the cells responsible for skin color.
• The study proposed a comprehensive theory that integrates existing knowledge about the disease's causes.
• Researchers observed that advancements in understanding vitiligo have led to the development of more effective and safer treatment options.

International journal of molecular sciences · 2021

Researchers observed that melatonin interacts with microglia, which are important immune cells in the brain, in various ways. These interactions may help protect against oxidative stress and neurodegeneration caused by factors like inflammation and infections. The study highlights the complex signaling processes involved in the brain's immune response and how melatonin influences them.

• Melatonin directly and indirectly affects microglia, contributing to brain health.
• It may play a role in reducing oxidative stress and preventing neurodegeneration.
• The study emphasizes the complexity of immune signaling in the central nervous system.

Dermatologic clinics · 2020

Researchers reviewed recent advances in phototherapy for vitiligo, a skin condition that can significantly affect quality of life. They found that narrowband ultraviolet B therapy is the preferred treatment for widespread vitiligo, while excimer laser is better for localized areas. The study highlights the need for clinicians to become more familiar with phototherapy to enhance its use in treating patients with vitiligo.

• Narrowband ultraviolet B is the first-line treatment for widespread vitiligo.
• Excimer laser therapy is recommended for treating localized vitiligo lesions.
• Many clinicians may not be fully utilizing phototherapy due to a lack of familiarity with prescribing it.

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2015

Researchers reviewed various treatments for undesirable skin pigmentation, particularly on the face. They found that while some prescription options exist, many over-the-counter products may be unsafe. The study emphasizes the importance of combination therapies and cautions against the use of potentially harmful substances like Melanotan I and certain bleaching creams.

• Researchers observed that Melanotan I can activate dysplastic nevi, which may pose risks.
• The study highlighted that the most effective treatment for hyperpigmentation involves a combination of therapies that inhibit melanin production and promote skin cell turnover.
• Researchers noted that common treatments like cryotherapy and laser are not recommended for individuals with darker skin types due to the risk of worsening pigmentation.